More articles from Oncology-Basic: Radiopharmaceutical Therapy

You have access
Whole-body imaging study with 177Lu-EDTMP in patients: As a new therapeutical agent of bone metastasis
Congjin Liu, Xingdang Liu, Hongyu Li, Zhifu Luo, Guangming Zhang and Yuankai Wang

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1167;
You have access
Therapeutic effect of biodegradable 32P-chromic phosphate-poly(l-lactide) seeds on human hepatocellular carcinoma in nude mice after intratumoral implantation
Guo qiang Shao, Zi-Zheng Wang, Feng Wang, Shao-hua Li and Qing-le Meng

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1163;
You have access
Peptide radionuclide receptor therapy (PRRT) with Lu-177-DOTA, Tyr3-octreotate (LuTATE): Risk factors, radiation dose and BED, impact on long-term renal toxicity
Roelf Valkema, Martijn Van Essen, Peter Kooij, Dik Kwekkeboom, Boen Liong Kam, Jaap Teunissen and Eric Krenning

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1156;
You have access
In vitro Auger cytotoxicity of breast cancer cells with ¹²⁵I delivered by an antisense nanoparticle
Xinrong Liu, Kayoko Nakamura, Yi Wang, Dengfeng Cheng, Minmin Liang, Nan Xiao, Ling Chen, Mary Rusckowski and Donald Hnatowich

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1154;
You have access
Anti-Cadherin 3 antibody labeled with Y-90 effectively inhibits tumor growth of non-small cell lung cancer xenograft in nude mice by radioimmunotherapy
Hirokazu Satoh, Fumiko Nomura, Youichi Aikawa, Romi Kotaka, Masahiko Watanabe, Yasutaka Saito, Akio Nagano, Akihiro Hino, Tadashi Matsuura and Yukio Sudo

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1151;
You have access
During repeated Sm-153-EDTMP therapy a temporary decrease in peripheral platelet count is balanced by an increased platelet function per cell
Helmut Sinzinger, Eva Trifina and Jukka Hiltunen

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1165;
You have access
Combined RNA interference of hexokinase II and radioiodine hNIS gene therapy in anaplastic thyroid cancer
Jung Eun Kim, Mi-Hye Hwang, You La Lee, Yong Hyun Jeon, Shin Young Jeong, Sang-Woo Lee, Byeong-Cheol Ahn and Jaetae Lee

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1168;
You have access
Long-term evaluation of renal toxicity with multiple doses of high activity 111-In-pentetreotide in patients with disseminated neuroendocrine tumors
Roozbeh Sharif, Jennifer Sims-Mourtada, Izabela Tworowska and Ebrahim Delpassand

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1158;
You have access
Deposition of Yttrium-90 microspheres (Y-90) in the gastroduodenum (GD) is associated with early stasis/reflux and likely caused by reflux to the gastroduodenal artery (GDA)
Manli Jiang, Josef Machac, Zhuangyu Zhang, Sherif Heiba, Karin Knesaurek, P. Stangl and Joshua Weintraub

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1162;
You have access
Does the modality of radionuclide treatment in NET have effect on PFS?
John Buscombe, Shaunak Navalkissoor, Christos Toumpanakis and Martyn Caplin

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1155;

Main menu

User menu

Search

More articles from Oncology-Basic: Radiopharmaceutical Therapy

Pages